Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.91 USD | -2.35% | -7.03% | -30.88% |
May. 02 | CUREVAC : A missed opportunity | |
Apr. 26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
Sales 2024 * | 59.49M 64.07M | Sales 2025 * | 79.05M 85.13M | Capitalization | 605M 652M |
---|---|---|---|---|---|
Net income 2024 * | -184M -198M | Net income 2025 * | -126M -136M | EV / Sales 2024 * | 8.21 x |
Net cash position 2024 * | 117M 126M | Net cash position 2025 * | 26.5M 28.54M | EV / Sales 2025 * | 7.32 x |
P/E ratio 2024 * |
-3.16
x | P/E ratio 2025 * |
-4.59
x | Employees | 1,086 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.65% |
Latest transcript on CureVac N.V.
1 day | -2.35% | ||
1 week | -7.03% | ||
Current month | +15.48% | ||
1 month | -1.36% | ||
3 months | -15.16% | ||
6 months | -46.21% | ||
Current year | -30.88% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 23-03-27 | |
Pierre Kemula
DFI | Director of Finance/CFO | 50 | 16-10-31 |
Malte Greune
COO | Chief Operating Officer | 59 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Tooman
BRD | Director/Board Member | 58 | 19-05-31 |
Michael Brosnan
BRD | Director/Board Member | 69 | 23-06-18 |
Director/Board Member | 67 | 22-06-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.74% | 17 M€ | -.--% | - | |
0.06% | 2 M€ | -.--% | ||
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 2.91 | -2.35% | 349,054 |
24-05-09 | 2.98 | +3.47% | 260,224 |
24-05-08 | 2.88 | -3.68% | 238,058 |
24-05-07 | 2.99 | +1.53% | 417,207 |
24-05-06 | 2.945 | -5.91% | 771,019 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.88% | 652M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- CVAC Stock